LETM1 and colorectal carcinoma: In this study, we investigated whether LETM1 down‐regulation stimulates the production of ROS to activate the AMP‐activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) signalling pathway and autophagy, eventually leading to inhibition of the proliferation and stemness of CRC cells.